Dana Gabuzda, PhD

Dr. Gabuzda presented unpublished data. She provided the below list of published manuscripts related to her talk:Dana Gabuzda

Chettimada S, Lorenz DR, Misra V, Dillon ST, Reeves RK, Manickam C, Morgello S, Kirk GD, Mehta SH, Gabuzda D. Exosome markers associated with immune activation and oxidative stress in HIV patients on antiretroviral therapy. Sci Rep. 2018 May 8;8(1):7227. doi: 10.1038/s41598-018-25515-4. PMID: 29740045

Mukerji SS, Misra V, Lorenz DR, Uno H, Morgello S, Franklin D, Ellis RJ, Letendre S, Gabuzda D. Impact of Antiretroviral Regimens on Cerebrospinal Fluid Viral Escape in a Prospective Multicohort Study of Antiretroviral Therapy-Experienced Human Immunodeficiency Virus-1-Infected Adults in the United States. Clin Infect Dis. 2018 Sep 28;67(8):1182-1190. doi: 10.1093/cid/ciy267. PMID: 29617912. PMCID: PMC5940833.

Mukerji SS, Misra V, Lorenz D, Cervantes-Arslanian AM, Lyons J, Chalkias S, Wurcel A, Burke D, Venna N, Morgello S, Koralnik IJ, Gabuzda D. Temporal Patterns and Drug Resistance in CSF Viral Escape Among ART-Experienced HIV-1 Infected Adults. J Acquir Immune Defic Syndr. 2017 Jun 1;75(2):246-255. doi: 10.1097/QAI.0000000000001362. PMID: 28328546 . PMCID: PMC5452976

Solomon IH, De Girolami U, Chettimada S, Misra V, Singer EJ, Gabuzda D. Brain and liver pathology, amyloid deposition, and interferon responses among older HIV-positive patients in the late HAART era.  BMC Infect Dis. 2017 Feb 17;17(1):151. doi: 10.1186/s12879-017-2246-7. PMID: 28212619. PMCID: PMC5316187.